| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/25/2009 | CN101584678A Sertaconazole antibacterial effervescing agent, preparation method and application thereof |
| 11/25/2009 | CN101584677A Trimebutine maleate sustained-release tablet |
| 11/25/2009 | CN101584676A Matrine sustained release preparation and preparing method thereof |
| 11/25/2009 | CN101584675A Slow-release avermectin tablet for livestock and poultry and preparing method thereof |
| 11/25/2009 | CN101584674A Venlafaxine hydrochloride sustained-release tablet preparation and preparation method thereof |
| 11/25/2009 | CN101584673A Levetiracetam tablet and preparation method |
| 11/25/2009 | CN101584672A Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof |
| 11/25/2009 | CN101584671A Cefazedone sodium medicament powder injection and method for synthesizing raw medicine of Cefazedone sodium |
| 11/25/2009 | CN101584670A Decitabine freeze-dried powder injection |
| 11/25/2009 | CN101584669A Melphalan freeze-dried powder injection |
| 11/25/2009 | CN101584668A Bendamustine hydrochloride freeze-dried powder injection |
| 11/25/2009 | CN101584667A Biodegradation type long-acting contraception microsphere and preparation method and application thereof |
| 11/25/2009 | CN101584666A Preparing method of proton pump inhibitor biological adhesive preparation |
| 11/25/2009 | CN101584665A Cefotiam hydrochloride medicament composition sterile powder injection and preparation method thereof |
| 11/25/2009 | CN101584664A Cefodizime sodium proliposome preparation and preparation method thereof |
| 11/25/2009 | CN101584663A Novel delivery system of Duoxitasai lipidosome for injection and preparation method thereof |
| 11/25/2009 | CN101584662A Etoposide lipidosome and preparation method thereof |
| 11/25/2009 | CN101584661A Preparation of sorafenib self-microemulsifying drug delivery system for oral administration or intravenous injection and use thereof |
| 11/25/2009 | CN101584660A Intravenous injection perilla alcohol submicron emulsion and preparation method thereof |
| 11/25/2009 | CN101584659A Docetaxel medicament composition injection and preparation method thereof |
| 11/25/2009 | CN101584658A Preparation method of amikacin sulfate injection |
| 11/25/2009 | CN101584657A Tilmicosin solution and preparation method thereof |
| 11/25/2009 | CN101584656A Novel use of amikacin sulfate injection |
| 11/25/2009 | CN101584655A High-purity salidroside injection preparation and preparation method thereof |
| 11/25/2009 | CN101584654A Ofloxacin nasal drops as well as preparation method and quality control method thereof |
| 11/25/2009 | CN101584653A Stable suppository containing roxithromycin |
| 11/25/2009 | CN101584652A Risperidone sustained-release gel injection and preparation method thereof |
| 11/25/2009 | CN100562340C A micro-emulsion type artificial tear |
| 11/25/2009 | CN100562335C Tibetan tonic for improving immunity and its preparing method |
| 11/25/2009 | CN100562332C Compound Chinese medicine for treating epilepsy |
| 11/25/2009 | CN100562330C The Chinese traditional medicinal powder for hemostasia, acesodyne, myogenic, sore, healing and its preparation method |
| 11/25/2009 | CN100562329C Decompression unction composition and method for producing same |
| 11/25/2009 | CN100562327C Health-care food for improving sleeping and its preparing process |
| 11/25/2009 | CN100562325C Composition of Chinese traditional medicine for treating tumor, and preparation method |
| 11/25/2009 | CN100562322C Colon target prepn. contg. 5-aminosalicylic acid, and its preparation method |
| 11/25/2009 | CN100562317C Granules containing acid-unstable chemical in large amount |
| 11/25/2009 | CN100562311C Cisplatin preparation method and its application method |
| 11/25/2009 | CN100562310C UV-stable transdermal patch |
| 11/25/2009 | CN100562309C Injectable composition of clopidogrel and its salt and preparation method thereof |
| 11/24/2009 | US7622556 Modified cytokines for use in cancer therapy |
| 11/24/2009 | US7622530 Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer |
| 11/24/2009 | US7622484 Such as asthma or chronic obstructive pulmonary disease; a corticoid such as mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or salt such as maleate |
| 11/24/2009 | US7622459 alkaline deproteination and subsequent elimination of water-soluble components consists in that the so obtained insoluble glucan is subsequently hydrated by wet grinding; heat sterilizing, results in a fungal polysaccharide with the beta -(1,3)-D-bond in the principal chain |
| 11/24/2009 | US7622280 Silicone based surfactant comprising hydrophobic and hydrophilic phases containing functional in vitro eukaryotic expression systems; compartmentalisation of transcription/translation reactions |
| 11/24/2009 | US7622141 Compositions containing a nopal cactus isolate and method for making same |
| 11/24/2009 | US7622138 gel comprising glycerol formal solvent, hydroxypropyl methylcellulose and a dissolved antibacterial agent Tobramycin, antifungal agent Terbinafine , and a steroid Betamethasone; controlled- or sustained-release; treating microbial infection of the skin, ear, or eye, especially for veterinary application |
| 11/24/2009 | US7622137 Dosage forms contained within a capsule or sachet |
| 11/24/2009 | US7622136 Transparent transdermal nicotine delivery devices |
| 11/24/2009 | US7622129 Nano-structured polymers for use as implants |
| 11/24/2009 | US7621907 Implantable drug delivery system |
| 11/24/2009 | US7621906 Method and apparatus to deliver drug and pacing therapy for treatment of cardiac disorders |
| 11/24/2009 | US7621905 Devices for intrabody delivery of molecules and systems and methods utilizing same |
| 11/24/2009 | US7621740 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
| 11/24/2009 | US7621300 Metering method for particulate material |
| 11/24/2009 | CA2507375C Use of rimexolone in the treatment of dry eye |
| 11/24/2009 | CA2493336C Composition for solubilization of paclitaxel and preparation method thereof |
| 11/24/2009 | CA2448030C Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester |
| 11/24/2009 | CA2445678C Paroxetine controlled release compositions |
| 11/24/2009 | CA2444880C Bifunctional-modified hydrogels |
| 11/24/2009 | CA2423930C Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| 11/24/2009 | CA2423836C Composition for the delivery of fentanyl |
| 11/24/2009 | CA2423384C New cross-linked derivatives of hyaluronic acid |
| 11/24/2009 | CA2422017C A transdermal electrotransport device for use in electrotransport drug delivery and method for manufacturing same |
| 11/24/2009 | CA2419877C Storage stable tretinoin and 4-hydroxy anisole containing topical composition |
| 11/24/2009 | CA2413337C Bioadhesive compositions and methods of preparation and use |
| 11/24/2009 | CA2404036C A method and apparatus for coating centers |
| 11/24/2009 | CA2403831C Coating and binding agent for pharmaceutical formulations having improved storage stability |
| 11/24/2009 | CA2392050C Pharmaceutical formulations containing zolmitriptan |
| 11/24/2009 | CA2391660C Responsive polymeric hollow particles |
| 11/24/2009 | CA2390153C Ingestible device for the release of substances at distinct locations in alimentary canal |
| 11/24/2009 | CA2383499C Drug delivery device |
| 11/24/2009 | CA2382651C Use of simple amino acids to form porous particles |
| 11/24/2009 | CA2382097C Product-structurant composition for personal care formulations |
| 11/24/2009 | CA2381860C Matrix adhering to nasal mucosa |
| 11/24/2009 | CA2378379C Fast-release extrudates and process for their production, and preparations obtainable therefrom |
| 11/24/2009 | CA2362756C Method for producing film-type dosage forms |
| 11/24/2009 | CA2343120C Use of an anthracycline derivative for the treatment of a liver tumor |
| 11/24/2009 | CA2313700C Device for enhancing transdermal agent flux |
| 11/24/2009 | CA2311109C Sugar-free hard coatings prepared from liquid mixtures of erythritol and sorbitol |
| 11/24/2009 | CA2279427C Use of low dose photodynamic therapy for reducing the effects of inflammation |
| 11/24/2009 | CA2274575C Preventive and curative agent for inflammatory bowel diseases |
| 11/24/2009 | CA2264647C Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 11/24/2009 | CA2247389C Agent for treatment of bladder troubles |
| 11/24/2009 | CA2192592C Cross-linked polymers for removing bile salts from a patient |
| 11/19/2009 | WO2009140649A2 Rab3b for the treatment and prevention of parkinson's disease |
| 11/19/2009 | WO2009140588A1 Silk polymer-based adenosine release: therapeutic potential for epilepsy |
| 11/19/2009 | WO2009140587A1 Pulmonary delivery of a fluoroquinolone |
| 11/19/2009 | WO2009140557A2 Modified release tolterodine formulations |
| 11/19/2009 | WO2009140527A1 Modified release formulations of dihydropyridine compounds and methods of making same |
| 11/19/2009 | WO2009140484A1 Processes for preparing amorphous drug substance |
| 11/19/2009 | WO2009140479A1 Amorphous solid dispersions |
| 11/19/2009 | WO2009140432A2 Micelles for intracellular delivery of therapeutic agents |
| 11/19/2009 | WO2009140341A2 Atorvastatin compositions |
| 11/19/2009 | WO2009140246A2 Intraocular drug delivery device and associated methods |
| 11/19/2009 | WO2009140162A1 Stable pharmaceutical formulations |
| 11/19/2009 | WO2009139984A2 Method of treatment for bladder dysfunction |
| 11/19/2009 | WO2009139939A2 Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents |
| 11/19/2009 | WO2009139924A2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 11/19/2009 | WO2009139888A1 Oral formulations of cytidine analogs and methods of use thereof |
| 11/19/2009 | WO2009139589A2 Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant |